Permar, Sallie R.
Weill Cornell Medicine,
United States
2024 Rank: 240751
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 1249 out of 71672 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 240751 | 200117 |
| Total Cites | 652 | 822 |
| H-index | 9 | 11 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 25 | 30 |
| Number of Single+First+Last Authored Papers | 126 | 126 |
| Total Cites to Single+First+Last Authored Papers | 326 | 404 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 531 | 608 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.35 |
| Self-Citation Percentage |
20.68%
|
|
Permar, Sallie R.
Weill Cornell Medicine,
United States
2023 Rank: 290519
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 1755 out of 68279 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 290519 | 201484 |
| Total Cites | 554 | 767 |
| H-index | 9 | 11 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 18 | 32 |
| Number of Single+First+Last Authored Papers | 120 | 120 |
| Total Cites to Single+First+Last Authored Papers | 267 | 396 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 466 | 543 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.41 |
| Self-Citation Percentage |
27.77%
|
|
Permar, Sallie R.
Weill Cornell Medicine,
United States
2022 Rank: 221771
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Immunology
Rank in SubField 1: 1576 out of 65731 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 221771 | 173157 |
| Total Cites | 638 | 825 |
| H-index | 11 | 13 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 17 | 27 |
| Number of Single+First+Last Authored Papers | 107 | 107 |
| Total Cites to Single+First+Last Authored Papers | 336 | 423 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 492 | 572 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.44 |
| Self-Citation Percentage |
22.67%
|
|
Permar, Sallie R.
Duke University School of Medicine,
United States
2021 Rank: 266097
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Microbiology
Rank in SubField 1: 1767 out of 64670 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 266097 | 189498 |
| Total Cites | 719 | 1024 |
| H-index | 12 | 15 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 32 | 60 |
| Number of Single+First+Last Authored Papers | 95 | 95 |
| Total Cites to Single+First+Last Authored Papers | 363 | 524 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 565 | 692 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.48 |
| Self-Citation Percentage |
29.79%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.